|
CA2534316A1
|
|
Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1
|
|
US2005020657A1
|
|
Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2
|
|
US6709651B2
|
|
Treatment of substance P-related disorders
|
|
US6337069B1
|
|
Method of treating rhinitis or sinusitis by intranasally administering a peptidase
|
|
DE19828588A1
|
|
Transportable device for intermittent compression to support the return transport of body fluid towards the heart, and use of this device
|
|
US6017879A
|
|
Template associated NPY Y2-receptor agonists
|
|
US5817912A
|
|
Transgenic mice with disrupted NPY Y1 receptor genes
|
|
EP0611248A1
|
|
Pharmaceutical composition for treating impotence containing an alpha-1-inhibitor and an alpha-2 inhibitor
|
|
EP0499010A1
|
|
A method for measuring the activity of angiotensin converting enzyme in biological samples
|
